7 Cash-Rich Dividend Stocks to Buy Now

In This Article:

The beautiful thing about cash-rich companies is not just that they perform well. Yes, their prices often rise exactly because their profits allow for the stockpiling of cash. That’s a strong sign of a company’s overall health, making their stocks investment-worthy in most cases. However, many of these companies are also dividend stocks to buy, as they return this excess cash to shareholders over time.

It’s simply math really. Companies that have more cash are those most likely to continue to pay dividends (and grow them over time). At the beginning of 2022, thirteen companies collectively held $1 trillion in reported cash and investments. Several of those companies are listed below as cash-rich dividend stocks to buy. 

Dividend stocks are strong investments in any economy. That’s as true as we head toward a recession as it was in early 2021, because dividends soften the blow of any capital losses. These cash payouts can allow investors to take the money if needed, or reinvest in more shares. Either way, long-term investors win. 

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Here are a list of seven top dividend stocks to buy for long-term investors in search of excellent total returns.

JNJ

Johnson & Johnson

$173.97

KO

Coca-Cola

$59.85

AVGO

Broadcom

$470.12

PG

Procter & Gamble

$134.67

AAPL

Apple

$153.34

PFE

Pfizer

$46.55

UNH

United Health

$555.15

Johnson & Johnson (JNJ)

A red Johnson & Johnson (JNJ) sign hangs inside in Moscow, Russia.
A red Johnson & Johnson (JNJ) sign hangs inside in Moscow, Russia.

Source: Alexander Tolstykh / Shutterstock.com

Starting off our list of dividend stocks to buy is Johnson & Johnson (NYSE:JNJ). Indeed, this company is in an enviable position right now. It has roughly $34 billion in cash on hand. Accordingly, this is a healthcare giant which may be looking for different pathways of how to utilize this capital right now. 

Many cash-rich pharmaceutical firms are taking advantage of this weaker economy by acquiring competitors at lower valuations. For now, it looks like JNJ will use the excess cash from its Covid-19 sales to strategize the splitting of its consumer division, Kenvue, by 2023. This move runs counter to other pharma firms that are rushing to snap up competitors currently. 

One thing is for sure: Johnson & Johnson is as sure to provide a dividend in the future. The company is among a select group of dividend stocks known as dividend kings. Dividend kings are stocks that have reported 50 or more years of dividend increases. To begin October, there were 46 such firms in existence. Johnson & Johnson will pay shareholders $1.13 per share on Dec. 6, and likely raise the dividend by a few cents again in 2023.